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A 8-month-old child was referred to our Dermatologic Unit for suspected Neurofibromatosis type 1 (NF 1), because of
the appearance, since few days after birth, of numerous café-au-lait spots (seven larger than 5 mm); no other sign
evocative of NF 1 was found. Her family history was remarkable for the presence of multiple café-au-lait spots in the
mother, the grandfather and two aunts. The family had been already examined for NF 1, but no sign evocative of the
disease was found. We then suspected Legius syndrome, a dominant disease characterized by a mild neurofibromatosis
1 phenotype. The diagnosis was confirmed by the finding of a mutation in SPRED1 gene, a feedback regulator of RAS/
MAPK signaling. Here, we discuss the differential diagnosis of cafè-au-lait spots and we briefly review the existing
literature about Legius syndrome.
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Cafè-au-lait macules (CALMs) are well-circumscribed,
light brown macules that can develop at birth or later
in life. They are common findings in Pediatrics, but they
can be a sign of many different conditions: they can be
isolated or related to a more complex syndrome. In the
last case it’s important to look for other signs evocative
of a syndrome in the patient or in his family.
We describe a healthy 8-month-old child with multiple
cafè-au-lait spots. Her family history was characterized
by the presence of CALMs in many members, but other
manifestations typical of Neurofibromatosis type 1 (NF 1)
were not described. Because of the presence of isolated
CALMs in many family members, we hypothesized a
Legius syndrome, an autosomal dominant disease charac-
terized by a mild NF 1 phenotype.Case
A 8-month-old female child was referred to our Dermato-
logic Unit for suspected Neurofibromatosis type 1 (NF 1),
because of the appearance of several café-au-lait macules
(CALMs) since first days of life. Her medical history was
otherwise unremarkable and growth and development* Correspondence: elisa.benelli@gmail.com
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unless otherwise stated.were appropriate for age. At physical exam, we noticed
that the child had multiple CALMs, of which 7 were larger
than 5 mm (Figure 1). No other clinical feature of NF 1
was found (i.e. Lisch nodules, axillar or inguinal freckles,
neurofibromas, gliomas).
On the other hand, the patient’s family history was in-
stead interesting (Figure 2): the mother, the grandfather
and two aunts had also multiple CALMs. In particular,
our patient’s mother presented more than 6 café-au-lait
spots larger than 15 mm (Figure 3). The youngest aunt
had also inguinal freckles and during childhood she had
suffered from benign epilepsy and mild scholar learning
disabilities, achieving a complete healing with growth. In
childhood our patient’s mother and her family were ex-
amined for NF 1, but no Lisch nodule or neurofibroma
was found. During those examinations, macrocephaly
was noticed in our patient’s mother. Since then, none of
the family members have developed any known compli-
cations of NF 1.
CALMs are common findings in healthy new-borns
and in children, but the presence of multiple macules,
large segmental lesions or the association with facial dys-
morphism, other cutaneous anomalies or unusual find-
ings at the physical exam, should arise the suspicion of a
more severe disease [1].
In our case, family history was highly suspicious for an
autosomal dominant disease, because the clinical sign (i.e.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Some of the child café-au-lait macules.
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CALMs are usually the first sign of NF 1 and it is well
known that the other clinical manifestations of NF 1 be-
came evident with age [2]. For this reason, we could not
exclude NF 1 right away in our patient, but it seemed un-
likely because of the lack of the other typical manifesta-
tions in the older family members (i.e. Lisch nodules,
neurofibromas, gliomas). However, some patients with a
NF1 phenotype characterized only by cutaneous signs and
specific mutations in NF1 gene (c.2970-2972 delAAT;
p.990delM) [3] (c.5425C > T;p.Arg1809Cys) [4], have beenFigure 2 The child’s family tree. N.1: the patient (a 8-month-old female c
mother and the grandfather had multiple cafè-au-lait spots; n.4: the young
epilepsy and mild scholar learning disabilities.recently described. Finally, neither the child nor the other
family members have nevus anemicus or juvenile xantho-
granuloma, which have been recently described be more
frequent in patients with NF 1 [5]. Other dominant auto-
somal diseases presenting with CALMs were excluded be-
cause of the lack of other associated manifestations. The
McCune Albright syndrome, for example, is characterized
by many endocrinopathies (in particular by precocious
puberty) and polyostotic fibrous dysplasia, but none of the
family members have ever presented one of these manifes-
tations. The LEOPARD syndrome, another autosomalhild) had multiple cafè-au-lait spots; n. 2 – 3 – 4–5: two aunts, the
est aunt had also inguinal freckles and in the past had suffered of
Figure 3 One of the mother’s café-au-lait macules.
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tigines” (freckles), even if CALMs can also be present.
Moreover, this syndrome is characterized by electrocardi-
ography conduction abnormalities, ocular hypertelorism,
pulmonary stenosis, abnormal genitalia, retarded growth
and sensorineural deafness.
Because of the lack of any sign other than CALMs and
freckles, we suspected Legius syndrome (LS), a dominant
disease characterized by a mild neurofibromatosis pheno-
type [6]. The diagnosis in our patient, her mother, the
grandfather and in the youngest aunt (the other aunt was
not willing for tests), was confirmed by the finding of a
pathogenic mutation, resulting in a stop codon, in the
SPRED1 gene (c.973C > T; p.Arg325*), a feedback regula-
tor of RAS/MAPK signaling and the responsible of the
disease [7].
Multiple café-au-lait spots, with or without freckles
and macrocephaly, characterize LS, whereas other com-
plications of NF 1 are absent [8]. As reported in a recent
review, other malformations are occasionally found in
patients with LS, such as Noonan-like face, pectus
excavatum or carinatum and lipomas [9]. Learning dis-
abilities and behavioral problems are also possible mani-
festations of the disease, as found by Denayer and al.,
who studied 15 patients with LS [10]. The same authors
reported that cognitive disabilities in LS are less severe
than in NF 1.
The disease was first described in 2007 by Brems and
colleagues, who identified that a heterozygous mutation
in SPRED1 gene was responsible of this mild neuro-
fibromatosis phenotype [11]. After 2007, more than 200
cases have been reported [6] and it has been demon-
strated that up to 2% of patients fulfilling diagnosticcriteria for NF 1, without NF1 gene mutations, have
instead SPRED1 mutations [7]. SPRED1 acts as a nega-
tive regulator of RAS pathway and interacts with neuro-
fibromin, the product of the NF1 gene [12]. Up to date,
many different allelic variants have been found, but no
genotype-phenotype correlation has been noted.Conclusion
Pediatricians must be aware of LS in all children with
CALMs, particularly in those without a family history for
NF1 complications. Identifying this condition is important,
to avoid the stress related to a NF1 diagnosis, but also to
start early cognitive and behavioral problems screening.
Written informed consent was obtained from the pa-
tient’s parent for publication of this Case report and any
accompanying images. A copy of the written consent is
available for review by the Editor-in-Chief of this journal.
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